Humanized anti-amyloid antibody

Details for Australian Patent Application No. 2006208226 (hide)

Owner Amgen Inc.

Inventors Shen, Wenyan; Biere-Citron, Anja Leona

Agent Shelston IP

Pub. Number AU-A-2006208226

PCT Pub. Number WO2006/081171

Priority 60/646,658 24.01.05 US

Filing date 23 January 2006

Wipo publication date 3 August 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/081171 Priority application(s): WO2006/081171

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208239-Ischemic biomarkers and their use to predict adverse neurological events from sugery

2006208213-Non-combustible reinforced cementitious lightweight panels and metal frame system for a fire wall and other fire resistive assemblies